The BCR:ABL1 fusion produces a chimeric protein with constitutive tyrosine kinase activity, resulting in unregulated cell proliferation and the development of CML[2]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.